Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

dexcel pharma ltd - valsartan - comprimé - 80 mg - composition pour un comprimé > valsartan : 80 mg - antagonistes de l’angiotensine ii, non associés.

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

dexcel pharma ltd - valsartan - comprimé - 40 mg - composition pour un comprimé > valsartan : 40 mg - antagonistes de l’angiotensine ii, non associés.

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

dexcel pharma gmbh (8000867) - atorvastatin-hemicalcium 0.25 h<2>o - filmtablette - teil 1 - filmtablette; atorvastatin-hemicalcium 0.25 h<2>o (39896) 83,54 milligramm

Malta - engelsk - Medicines Authority

dexcel pharma gmbh carl-zeiss-straße 2 63755 alzenau, germany - prucalopride succinate - film-coated tablet - prucalopride succinate 1 mg - drugs for constipation

Malta - engelsk - Medicines Authority

dexcel pharma gmbh carl-zeiss-straße 2 63755 alzenau, germany - prucalopride succinate - film-coated tablet - prucalopride succinate 2 mg - drugs for constipation

Israel - hebraisk - Ministry of Health

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 250 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Israel - hebraisk - Ministry of Health

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 500 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Israel - hebraisk - Ministry of Health

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 750 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Israel - hebraisk - Ministry of Health

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 1000 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

dexcel-pharma ltd - losartan potassium - oral tablet - 100mg